Clinical Trial Update: CAV Regimen for R/R Ph- B-ALL [NA]

View source ↗

Summary

A clinical trial update for a CAV regimen in relapsed/refractory Philadelphia-negative B-ALL, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• Vincristine (vincristine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Lymphoblastic Leukemia | NA | Status: RECRUITING